Noticias de JAGX_US

Noticias del mercado

Últimas noticias sobre JAGX_US — 356 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: JAGX_US ✕ 356 resultados

02/04/2026 JAGX_US — ACCESS Newswire

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress

Jaguar continúa su fuerte enfoque estratégico en su programa de desarrollo global de crofelemer para indicaciones de insuficiencia intestinal (IF) de enfermedades raras; todos los pacientes...

02/04/2026 JAGX_US — Stock Titan

Children needing IV nutrition cut support 12%-37% in crofelemer study

02/04/2026 JAGX_US — Yahoo Finance

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress

01/04/2026 JAGX_US — Stock Titan

Jaguar Health (NASDAQ: JAGX) notifies SEC of late 10-K; will file within 15 days

01/04/2026 JAGX_US — TipRanks

Jaguar Health Delays Annual Form 10-K Filing

27/03/2026 JAGX_US — AD HOC NEWS

Jaguar Health Inc Stock: Commercial-Stage Pharma Targeting Gastrointestinal Disorders in Humans and

24/03/2026 JAGX_US — Stock Titan

Jaguar Health (NASDAQ: JAGX) eyes major reverse splits and note-for-equity issuance

21/03/2026 JAGX_US — ACCESS Newswire ES ← EN

Jaguar Health anuncia la disponibilidad en línea de una presentación sobre el síndrome del intestino corto (SIC) realizada por el Dr. Mohamad Miqdady en el Congreso Elite Ped-GI en Abu Dhabi

Jaguar Health anuncia la disponibilidad en línea de una presentación sobre el síndrome del intestino corto (SIC) realizada por el Dr. Mohamad Miqdady en el Congreso Elite Ped-GI en Abu…

18/03/2026 JAGX_US — Stock Titan

FDA backs longer crofelemer trial for lethal ultra-rare childhood MVID

18/03/2026 JAGX_US — Yahoo Finance

FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)

18/03/2026 JAGX_US — GuruFocus

Jaguar Health (JAGX) Advances Pediatric Crofelemer Study

16/03/2026 JAGX_US — Yahoo Finance

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression

16/03/2026 JAGX_US — Stock Titan

Can coca leaves help keep weight off after GLP-1 drugs end?

16/03/2026 JAGX_US — Investing.com

Jaguar Health unit begins coca extract study for weight management